Kiromic BioPharma, Inc. (KRBP)
OTCMKTS: KRBP · Delayed Price · USD
2.240
+0.090 (4.19%)
Jul 2, 2024, 2:37 PM EDT - Market closed
Kiromic BioPharma Market Cap
Kiromic BioPharma has a market cap or net worth of $3.46 million as of July 2, 2024. Its market cap has decreased by -47.65% in one year.
Market Cap
3.46M
Enterprise Value
13.36M
1-Year Change
-47.65%
Ranking
n/a
Category
Stock Price
$2.24
Market Cap Chart
Since the IPO on October 16, 2020, Kiromic BioPharma's market cap has decreased from $88.00M to $3.46M, a decrease of -96.07%. That is a compound annual growth rate of -67.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 13, 2023 | 1.70M | -48.48% |
| Dec 30, 2022 | 3.30M | -86.02% |
| Dec 31, 2021 | 23.60M | -62.00% |
| Dec 31, 2020 | 62.10M | -29.43% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 860.48B |
| Novo Nordisk | 629.27B |
| UnitedHealth Group | 468.72B |
| Johnson & Johnson | 351.76B |
| Merck & Co. | 313.56B |
| AbbVie | 302.88B |
| AstraZeneca | 241.81B |
| Thermo Fisher | 211.09B |